Harout Semerjian - Net Worth and Insider Trading
Harout Semerjian Net Worth
The estimated net worth of Harout Semerjian is at least $35,250 dollars as of 2023-10-03. Harout Semerjian is the CEO of GlycoMimetics Inc and owns about 25,000 shares of GlycoMimetics Inc (GLYC) stock worth over $35,250. Details can be seen in Harout Semerjian's Latest Holdings Summary section.
Transaction Summary of Harout Semerjian
Harout Semerjian Insider Ownership Reports
Harout Semerjian Latest Holdings Summary
Harout Semerjian currently owns a total of 1 stock. Harout Semerjian owns 25,000 shares of GlycoMimetics Inc (GLYC) as of November 11, 2022, with a value of $35,250.
Harout Semerjian Form 4 Trading Tracker
According to the SEC Form 4 filings, Harout Semerjian has made a total of 1 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 25,000 shares on November 11, 2022, which cost Harout Semerjian around $32,250.
Insider Trading History of Harout Semerjian
Harout Semerjian Trading Performance
GuruFocus tracks the stock performance after each of Harout Semerjian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harout Semerjian is 180.65%. GuruFocus also compares Harout Semerjian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harout Semerjian within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harout Semerjian's insider trading performs compared to the benchmark.
Performance of Harout Semerjian
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||68.41||178.21||36.87|
Harout Semerjian Ownership Network
Ownership Network List of Harout Semerjian
Ownership Network Relation of Harout Semerjian
Harout Semerjian Owned Company Details
What does Immunomedics Inc do?
Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.
Who are the key executives at Immunomedics Inc?
Harout Semerjian is the director & President and CEO of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and Chief Human Resources Officer Kurt J. Andrews .
Immunomedics Inc (IMMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunomedics Inc Insider Transactions
Harout Semerjian Mailing Address
Above is the net worth, insider trading, and ownership report for Harout Semerjian. You might contact Harout Semerjian via mailing address: 300 The American Road, C/o Immunomedics, Inc., Morris Plains Nj 07950.